Armstrong discusses the positive time-to-healing data from the phase 2 LEGenD-1 study, investigating anatomically targeted delivery of AMG0001.
David Armstrong, DPM, PhD
Advertisement
David Armstrong, MD, PhD, is a distinguished professor of surgery and neurological surgery at Keck School of Medicine of USC.
Articles by David Armstrong, DPM, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
AXIOMATIC-TKR: Milvexian Decouples Thrombosis, Hemostasis in DVT
2
SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes
3
REMAIN-1: Improved GLP-1-Induced Weight Loss Retention With Revita DMR System
4
FDA Grants Obinutuzumab Priority Review as Primary Membranous Nephropathy’s Potential First Therapy
5